Edward A. Levine

ORCID: 0000-0002-7683-9502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intraperitoneal and Appendiceal Malignancies
  • Appendicitis Diagnosis and Management
  • Ovarian cancer diagnosis and treatment
  • Breast Cancer Treatment Studies
  • Gastric Cancer Management and Outcomes
  • Breast Lesions and Carcinomas
  • Pancreatic and Hepatic Oncology Research
  • Neuroendocrine Tumor Research Advances
  • Gastrointestinal Tumor Research and Treatment
  • Occupational and environmental lung diseases
  • Hernia repair and management
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Adrenal and Paraganglionic Tumors
  • Sarcoma Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Pituitary Gland Disorders and Treatments
  • Colorectal Cancer Surgical Treatments
  • Metastasis and carcinoma case studies
  • Cancer and Skin Lesions
  • Colorectal Cancer Treatments and Studies
  • Cutaneous Melanoma Detection and Management
  • Colorectal and Anal Carcinomas
  • Global Cancer Incidence and Screening
  • BRCA gene mutations in cancer
  • Breast Implant and Reconstruction

Atrium Health Wake Forest Baptist
2016-2025

Wake Forest University
2015-2024

Hospices Civils de Lyon
2009-2024

University of Messina
2024

Institut National d'Oncologie
2024

Agostino Gemelli University Polyclinic
2024

Istituti di Ricovero e Cura a Carattere Scientifico
2024

Policlinico Abano Terme
2024

Ospedale Policlinico San Martino
2024

Wake Forest Baptist Comprehensive Cancer Center
2015-2023

The three principal studies dedicated to the natural history of peritoneal carcinomatosis (PC) from colorectal cancer consistently showed median survival ranging between 6 and 8 months. New approaches combining cytoreductive surgery perioperative intraperitoneal chemotherapy suggest improved survival.A retrospective multicenter study was performed evaluate international experience with this combined treatment identify prognostic indicators. All patients had (intraperitoneal chemohyperthermia...

10.1200/jco.2004.10.012 article EN Journal of Clinical Oncology 2004-08-14

This phase III clinical trial evaluated the impact on disease-free survival (DFS) of adding oxaliplatin to bolus weekly fluorouracil (FU) combined with leucovorin as surgical adjuvant therapy for stage II and colon cancer.Patients who had undergone a potentially curative resection were randomly assigned either FU 500 mg/m2 intravenous (IV) 6 weeks plus IV during each 8-week cycle three cycles (FULV), or same FULV regimen 85 administered 1, 3, 5 (FLOX).A total 2,407 patients (96.6%) 2,492...

10.1200/jco.2006.08.2974 article EN Journal of Clinical Oncology 2007-05-01

Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease. The purpose of our study was to evaluate outcome and long-term survival after cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC) consolidated through international registry study.A retrospective multi-institutional established collaborative efforts participating units affiliated with the Peritoneal Surface Oncology Group International.Two...

10.1200/jco.2011.39.7166 article EN Journal of Clinical Oncology 2012-05-22

Purpose This multi-institutional registry study evaluated cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse malignant peritoneal mesothelioma (DMPM). Patients and Methods A data that included 405 patients DMPM treated by a uniform approach used CRS HIPEC was established. The primary end point overall survival. secondary evaluation of prognostic variables Results Follow-up complete in 401 (99%). median follow-up period the who were alive...

10.1200/jco.2009.23.9640 article EN Journal of Clinical Oncology 2009-11-17

Pseudomyxoma peritonei is a clinical term for gelatinous ascites, usually secondary to an appendiceal tumor. The pathologic classification of pseudomyxoma and its associated tumors has been plagued with controversy confusing terminology. In effort clarify this, we reviewed the pathology 101 patients, all treated at our institution from 1993 2005, origin. All patients were uniformly standardized protocol. This largest series solely devoted neoplasia ascites. cases assigned, according...

10.1097/01.pas.0000202039.74837.7d article EN The American Journal of Surgical Pathology 2006-05-01

Restorative yoga (RY) is a gentle type of that may be beneficial for cancer patients and post-treatment survivors. Study goals were: to determine the feasibility implementing RY intervention women with breast cancer; examine group differences in self-reported emotional, health-related quality life, symptom outcomes.

10.1002/pon.1503 article EN Psycho-Oncology 2009-02-25

<h3>Importance</h3> Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. <h3>Objectives</h3> To evaluate outcomes after cytoreductive surgery (CRS) and HIPEC compared with CRS alone patients PMP. <h3>Design, Setting, Participants</h3> This cohort study analyzed data from Peritoneal Surface Oncology Group International (PSOGI) registry, including 1924 histologically confirmed PMP due to an appendiceal...

10.1001/jamasurg.2020.6363 article EN JAMA Surgery 2021-01-27

Abstract: We sought to prospectively assess the diagnostic performance of a high-resolution positron emission tomography (PET) scanner using mild breast compression (positron mammography [PEM]). Data were collected on concomitant medical conditions potential confounding factors. At four centers, 94 consecutive women with known cancer or suspicious lesions received 18F-fluorodeoxyglucose (FDG) intravenously, followed by PEM scans. Readers provided clinical histories and x-ray mammograms (when...

10.1111/j.1075-122x.2006.00269.x article EN The Breast Journal 2006-07-01

Abstract Background Evaluation of peritoneal metastases by computed tomography (CT) scans is challenging and has been reported to be inaccurate. Methods A multi‐institutional prospective observational registry study patients with carcinomatosis from colorectal cancer was conducted a subset analysis performed examine index (PCI) based on CT intraoperative exploration. Results Fifty‐two (mean age 52.6 ± 12.4 years) 16 institutions were included in this study. Inaccuracies CT‐based assessment...

10.1002/jso.21601 article EN Journal of Surgical Oncology 2010-10-23

In Brief Objective: To evaluate the utility of 18F-FDG-PET in predicting response to concomitant chemoradiation locally-advanced esophageal cancer. Summary Background Data: Approximately 25% cancer patients experience a pathologic complete (pCR) preoperative therapy. Computed tomography, endoscopy, and endoscopic ultrasound are unable identify experiencing pCR. Growing evidence supports use staging its ability detect occult metastatic lymph nodal disease. The identification with pCR could...

10.1097/01.sla.0000208430.07050.61 article EN Annals of Surgery 2006-03-20

Genetic variations in DNA repair may impact functions, damage and breast cancer risk. Using data/samples collected from the first 752 Caucasians 141 African-Americans an ongoing case-control study, we examined association between risk 18 non-synonymous single-nucleotide polymorphisms (nsSNPs) four pathways-(i) base excision repair: ADPRT V762A, APE1 D148E, XRCC1 R194W/R280H/R399Q POLD1 R119H; (ii) nucleotide ERCC2 D312N/K751Q, ERCC4 R415Q, ERCC5 D1104H XPC A499V/K939Q; (iii) mismatch MLH1...

10.1093/carcin/bgn193 article EN Carcinogenesis 2008-08-13

Abstract BACKGROUND: Currently, no tumor‐node‐metastasis (TNM) staging system exists for patients with diffuse malignant peritoneal mesothelioma (DMPM). The primary objective was to formulate a clinicopathological through the identification of significant prognostic parameters. METHODS: Eight international institutions prospectively collected data on who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy contributed registry. Two hundred ninety‐four had complete...

10.1002/cncr.25640 article EN Cancer 2010-11-18

Anthracycline- and taxane-based three-drug chemotherapy regimens have proven benefit as adjuvant therapy for early-stage breast cancer. This trial (NSABP B-38; Combination Chemotherapy in Treating Women Who Have Undergone Surgery Node-Positive Breast Cancer) asked whether the incorporation of a fourth drug could improve outcomes relative to two standard provided direct comparison those regimens.We randomly assigned 4,894 women with node-positive cancer six cycles docetaxel, doxorubicin,...

10.1200/jco.2012.48.1275 article EN Journal of Clinical Oncology 2013-08-13

To determine whether [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) can delineate patients with esophageal cancer who may not benefit from esophagectomy after chemoradiotherapy.We reviewed records of 163 histologically confirmed stage I to IVA receiving chemoradiotherapy or without resection curative intent. All received surgical evaluation. Initial and postchemoradiotherapy FDG-PET scans prognostic/treatment variables were analyzed. complete response (PET-CR) was defined...

10.1200/jco.2010.30.7702 article EN Journal of Clinical Oncology 2010-09-28

Tumor-infiltrating myeloid cells are the most abundant leukocyte population within tumors. Molecular cues from tumor microenvironment promote differentiation of immature toward an immunosuppressive phenotype. However, in situ dynamics transcriptional reprogramming underlying this process poorly understood. Therefore, we applied single cell RNA-seq (scRNA-seq) to computationally investigate cellular composition and adjacent normal tissues 4 early-stage non-small lung cancer (NSCLC) patients....

10.1002/cam4.2113 article EN cc-by Cancer Medicine 2019-04-29
Coming Soon ...